Objective: In the context of controversy and uncertainty about the role of selective serotonin reuptake inhibitors (SSRIs) for the treatment of depressive disorders in children and adolescents, we consider the evidence of the benefits and risks of this class of medication and the possible role of shared decision-making as a practical way to guide clinicians, young people and their families through treatment decisions.
Conclusion: We suggest that there is an imperative for clinicians to engage young people in a process of shared decision-making, given the uncertainties about SSRI medication in this age group. Shared decision-making provides a way for clinicians to engage young people and ensure they receive the treatment required for this disorder, the potential outcomes of which are severe.
Get full access to this article
View all access options for this article.
References
1.
VitielloBZuvekasSHNorquistGS. National estimates of antidepressant medication use among us children, 1997–2002. Journal of the American Academy of Child and Adolescent Psychiatry2006; 45: 271–279.
2.
DubickaBHadleySRobertsC. Suicidal behaviour in youths with depression treated with new-generation antidepressants: Meta-analysis. British Journal of Psychiatry2006; 189: 393–398.
3.
HammadTALaugrenTRacoosinJ. Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry2006; 63: 332–339.
4.
GibbonsRDBrownCHHurK. Early evidence on the effects of regulators’ suicidality warnings on ssri prescriptions and suicide in children and adolescents. American Journal of Psychiatry2007; 164: 1356–1363.
5.
BrentDA. Antidepressants and pediatric depression – the risk of doing nothing. New England Journal of Medicine2004; 351: 1598–1601.
6.
WhittingtonCJKendallTFonagyPCottrellDCotgroveABoddingtonE. Selective serotonin reuptake inhibitors in childhood depression: Systematic review of published versus unpublished data. Lancet2004; 363: 1341–1345.
7.
MoncrieffJCohenD. Rethinking models of psychotropic drug action. Psychotherapy Psychosomatics2005; 74: 145–153.
8.
JureidiniJNDoeckeCJMansfieldPRHabyMMMenkesDBTonkinAL. Efficacy and safety of antidepressants for children and adolescents. British Medical Journal2004; 328: 879–883.
9.
HetrickSE, MerryS, McKenzieJ, SindahlP, ProctorM. Selective serotonin reuptake inhibitors (SSRIS) for depressive disorders in children and adolescents. Cochrane Database of Systematic Reviews. In: The Cochrane Library 2007; Issue 3.
ZimmermanMMcGlincheyJBPosternakMAFriedmanMBoerescuDAttiullahN. Discordance between self-reported symptom severity and psychosocial functioning ratings in depressed outpatients: Implications for how remission from depression should be defined. Psychiatry Research2006; 141: 185–191.
12.
EmslieGJHeiligensteinJHWagnerKD. Fluoxetine for acute treatment of depression in children and adolescents: A placebo-controlled randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry2002; 41: 1205–2015.
13.
JensenP. After tads, can we measure up, catch up, and ante up?. Journal of the American Academy of Child and Adolescent Psychiatry2006; 45: 1456–1460.
14.
GibbonsRDBrownCHHurKMarcusSMBhaumikDKMannJJ. Relationship between antidepressants and suicide attempts: An analysis of the veterens health administration data. American Journal of Psychiatry2007; 164: 1044–1038.
15.
SimonGESavarinoJ. Suicide attempts among patients starting depression treatment with medication or psychotherapy. American Journal of Psychiatry2007; 164: 1029–1034.
16.
LibbyAMBrentDAMorratoEHOrtonHDAllenRValuckRJ. Decline in treatment of pediatric depression after fda advisory on risk of suicidality with SSRIS. American Journal of Human Genetics2007; 164: 884–891.
17.
GoodyerIDubickaBWilkinsonP. Selective serotonin reuptake inhibitors (SSRIS) and routine specialist care with and without cognitive behaviour therapy in adolescents with major depression: Randomised controlled trial. British Medical Journal2007; 335 (7611)142.
18.
TADS Team. The treatment for adolescents with depression study (tads): Long-term effectiveness and safety outcomes. Archives of General Psychiatry2007; 64: 1132–1144.
19.
ClarkeGDebarLLynchF. A randomized effectiveness trial of brief cognitive-behavioral therapy for depressed adolescents receiving antidepressant medication. Journal of the American Academy of Child and Adolescent Psychiatry2005; 44: 888–898.
20.
BridgeJAIyengarSSalaryCB. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: A meta-analysis of randomized controlled trials. Journal of the American Medical Association2007; 297: 1683–1696.
21.
LeckmanJFKingRA. A developmental perspective on the controversy surrounding the use of SSRIS to treat paediatric depression. American Journal of Psychiatry2007; 164: 1304.
22.
National Institute for Health and Clinical Excellence (NICE). Depression in Children and Young People: Identification and Management in Primary, Community and Secondary Care. Leicester: The British Psychological Society, 2005.
23.
DeeganPDrakeR. Shared decision making and medication management in the recovery process. Psychiatric Services2006; 57: 1636–1639.
24.
BenbassatJPilpelDTidharM. Patients’ preferences for participation in clinical decision making: A review of published surveys. Behavioral Medicine1998; 24: 81–88.
25.
AdamsJRDrakeREWolfordGL. Shared decision-making preferences of people with severe mental illness. Psychiatric Services2007; 58: 1219–1221.
26.
BrittenNStevensonFGafarangaJBarryCBradleyC. The expression of aversion to medicines in general practice consultations. Social Science Medicine2004; 59: 1495–1503.
27.
O'ConnorAM, StaceyD, EntwistleV, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database of Systematic Reviews, 2003.
28.
EdwardsAElwynG. Inside the black box of shared decision making: Distinguishing between the process of involvement and who makes the decision. Health Expectations2006; 9: 307–320.
29.
JoostenEAGDeFuentes-MerillasLde WeertGHSenskyTvan der StaakCPFde JongCAJ. Systematic review of the effects of shared decision-making on patient satisfaction, treatment adherence and health status. Psychotherapy and Psychosomatics2008; 77: 219–226.
30.
LohASimonDWillsCKristonLNieblingWHarterM. The effects of a shared decision-making intervention in primary care of depression: A cluster-randomized controlled trial. Patient Education and Counseling2007; 67: 324–332.
31.
WhiskeyETaylorD. Evaluation of an antipsychotic information sheet for patients. International Journal of Psychiatry in Clinical Practice2005; 9: 264–270.
32.
WillsCHolmes-RovnerM. Preliminary validation of the satisfaction with decision scale with depressed primary care patients. Health Expectations2003; 6: 149–159.
33.
ChilversCDeweyMFieldingK. Antidepressant drugs and generic counselling for treatment of major depression in primary care: Randomised trial with patient preference arms. British Medical Journal2001; 322: 772–776.
34.
SimonGVon KorffMLudmanE. Cost-effectiveness of a program to prevent depression relapse in primary care. Medical Care2002; 10: 941–950.
35.
HamannJMischoCLangerBLeuchtSKisslingW. Physicians’ and patients’ involvement in relapse prevention with antipsychotics in schizophrenia. Psychiatric Services2005; 56: 1448–1450.
36.
SimonJPillingSBurbeckRGoldbergD. Treatment options in moderate and severe depression: Decision analysis supporting a clinical guideline. British Journal of Psychiatry2006; 189: 494–501.
37.
SealeCChaplinRLelliottPQuirkA. Sharing decisions in consultations involving anti-psychotic medication: A qualitative study of psychiatrists’ experiences. Social Science and Medicine2006; 62: 2861–2873.
38.
GoossensenAZiklstraPKoopmanschapM. Measuring shared decision making processes in psychiatry: Skills versus patient satisfaction. Patient Education and Counseling2007; 67: 50–56.
39.
HamannJAdjanSLeuchtSKisslingW. Psychiatric decision making in the adoption of a new antipsychotic in germany. Psychiatric Services2006; 57: 700–703.
40.
CleverSFordDRubensteinL. Primary care patients’ involvement in decision-making is associated with improvement in depression. Medical Care2006; 44: 398–405.
41.
LohALeonhartRWillsCSimonDHarterM. The impact of patient participation on adherence and clinical outcome in primary care of depression. Patient Education and Counseling2007; 65: 69–78.
